Literature DB >> 10233059

Quantifying aggregation of IgE-FcepsilonRI by multivalent antigen.

W S Hlavacek1, A S Perelson, B Sulzer, J Bold, J Paar, W Gorman, R G Posner.   

Abstract

Aggregation of cell surface receptors by multivalent ligand can trigger a variety of cellular responses. A well-studied receptor that responds to aggregation is the high affinity receptor for IgE (FcepsilonRI), which is responsible for initiating allergic reactions. To quantify antigen-induced aggregation of IgE-FcepsilonRI complexes, we have developed a method based on multiparameter flow cytometry to monitor both occupancy of surface IgE combining sites and association of antigen with the cell surface. The number of bound IgE combining sites in excess of the number of bound antigens, the number of bridges between receptors, provides a quantitative measure of IgE-FcepsilonRI aggregation. We demonstrate our method by using it to study the equilibrium binding of a haptenated fluorescent protein, 2,4-dinitrophenol-coupled B-phycoerythrin (DNP25-PE), to fluorescein isothiocyanate-labeled anti-DNP IgE on the surface of rat basophilic leukemia cells. The results, which we analyze with the aid of a mathematical model, indicate how IgE-FcepsilonRI aggregation depends on the total concentrations of DNP25-PE and surface IgE. As expected, we find that maximal aggregation occurs at an optimal antigen concentration. We also find that aggregation varies qualitatively with the total concentration of surface IgE as predicted by an earlier theoretical analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233059      PMCID: PMC1300214          DOI: 10.1016/s0006-3495(99)77397-2

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  54 in total

1.  Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data.

Authors:  D G Myszka; X He; M Dembo; T A Morton; B Goldstein
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

2.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.

Authors:  D S Lyons; S A Lieberman; J Hampl; J J Boniface; Y Chien; L J Berg; M M Davis
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

3.  Equilibrium binding of multivalent ligands to cells: effects of cell and receptor density.

Authors:  B Sulzer; A S Perelson
Journal:  Math Biosci       Date:  1996-07-15       Impact factor: 2.144

4.  Kinetics of multivalent antigen DNP-BSA binding to IgE-Fc epsilon RI in relationship to the stimulated tyrosine phosphorylation of Fc epsilon RI.

Authors:  K Xu; B Goldstein; D Holowka; B Baird
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

5.  Exploiting the difference between intrinsic and extrinsic kinases: implications for regulation of signaling by immunoreceptors.

Authors:  C Wofsy; C Torigoe; U M Kent; H Metzger; B Goldstein
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

6.  syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction.

Authors:  O El-Hillal; T Kurosaki; H Yamamura; J P Kinet; A M Scharenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  The kinetics of bivalent ligand-bivalent receptor aggregation: ring formation and the breakdown of the equivalent site approximation.

Authors:  R G Posner; C Wofsy; B Goldstein
Journal:  Math Biosci       Date:  1995-04       Impact factor: 2.144

Review 8.  Antigen-mediated IGE receptor aggregation and signaling: a window on cell surface structure and dynamics.

Authors:  D Holowka; B Baird
Journal:  Annu Rev Biophys Biomol Struct       Date:  1996

9.  Flow cytometric analysis of T-independent antigen binding to dinitrophenyl-specific cells.

Authors:  S L Woodard; M Aldo-Benson; D A Roess; B G Barisas
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

10.  Simultaneous cross-linking by two nontriggering bivalent ligands causes synergistic signaling of IgE Fc epsilon RI complexes.

Authors:  R G Posner; K Subramanian; B Goldstein; J Thomas; T Feder; D Holowka; B Baird
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

View more
  12 in total

1.  T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model.

Authors:  J D Stone; J R Cochran; L J Stern
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Kinetic proofreading models for cell signaling predict ways to escape kinetic proofreading.

Authors:  W S Hlavacek; A Redondo; H Metzger; C Wofsy; B Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

3.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

4.  Trivalent antigens for degranulation of mast cells.

Authors:  Richard G Posner; Dianliang Geng; Seth Haymore; James Bogert; Israel Pecht; Arieh Licht; Paul B Savage
Journal:  Org Lett       Date:  2007-08-11       Impact factor: 6.005

5.  Modeling multivalent ligand-receptor interactions with steric constraints on configurations of cell-surface receptor aggregates.

Authors:  Michael I Monine; Richard G Posner; Paul B Savage; James R Faeder; William S Hlavacek
Journal:  Biophys J       Date:  2010-01-06       Impact factor: 4.033

6.  A general model of multivalent binding with ligands of heterotypic subunits and multiple surface receptors.

Authors:  Zhixin Cyrillus Tan; Aaron S Meyer
Journal:  Math Biosci       Date:  2021-10-09       Impact factor: 2.144

7.  A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids.

Authors:  Başar Bilgiçer; Samuel W Thomas; Bryan F Shaw; George K Kaufman; Vijay M Krishnamurthy; Lara A Estroff; Jerry Yang; George M Whitesides
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

8.  Dissecting FcγR Regulation through a Multivalent Binding Model.

Authors:  Ryan A Robinett; Ning Guan; Anja Lux; Markus Biburger; Falk Nimmerjahn; Aaron S Meyer
Journal:  Cell Syst       Date:  2018-06-27       Impact factor: 10.304

9.  Optimal aggregation of FcεRI with a structurally defined trivalent ligand overrides negative regulation driven by phosphatases.

Authors:  Avanika Mahajan; Dipak Barua; Patrick Cutler; Diane S Lidke; Flor A Espinoza; Carolyn Pehlke; Rachel Grattan; Yuko Kawakami; Chang-Shung Tung; Andrew R M Bradbury; William S Hlavacek; Bridget S Wilson
Journal:  ACS Chem Biol       Date:  2014-05-15       Impact factor: 5.100

Review 10.  IgE immunotherapy: a novel concept with promise for the treatment of cancer.

Authors:  Debra H Josephs; James F Spicer; Panagiotis Karagiannis; Hannah J Gould; Sophia N Karagiannis
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.